EUVIMEDEUVIMED entdecken
Übersichtsarbeit

New and Emerging Options for the Treatment of Non–Muscle-Invasive Bladder Cancer

David J Nusbaum, James E Ferguson, Philippe E Spiess, Roger Li, Andrew M Fang, Debasish Sundi, Scott M Gilbert, Charles C Peyton

Journal of the National Comprehensive Cancer Network · 2026-11 · 24 (11)

DOI: 10.6004/jnccn.2026.7061 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-11. Verfasst von David J Nusbaum und 7 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL. Hauptthemen laut MEDLINE: Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Risk-adapted management of non–muscle-invasive bladder cancer (NMIBC) ranges from surveillance for low-risk tumors to intravesical chemotherapy or bacillus Calmette-Guérin (BCG) for intermediate- and high-risk disease. Radical cystectomy is reserved for patients experiencing cancer recurrence or progression despite treatment and for those with very high-risk features. The landscape of management options is rapidly evolving, with several new agents recently approved for BCG-unresponsive disease. In addition, many clinical trials are ongoing across the spectrum of NMIBC disease states. This review aims to summarize new and emerging treatment options in NMIBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-Muscle Invasive Bladder NeoplasmsUrinary Bladder NeoplasmsNeoplasm Recurrence, LocalHumansBCG VaccineAdministration, IntravesicalCystectomy

Stichwörter der Autor:innen

BCG-unresponsiveNonmuscle invasive bladder cancerUrothelial carcinomaintravesical therapy

Substanzen

BCG Vaccine

Autor:innen und Institutionen

  • 1Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL.
  • 2Department of Urology, University of Alabama at Birmingham, Birmingham, AL.
  • 3Department of Urology, Ohio State University, Columbus, OH.

Zitieren

APA

Nusbaum, D. J., Ferguson, J. E., Spiess, P. E., Li, R., Fang, A. M., Sundi, D., Gilbert, S. M., & Peyton, C. C. (2026). New and Emerging Options for the Treatment of Non–Muscle-Invasive Bladder Cancer. Journal of the National Comprehensive Cancer Network, 24(11). https://doi.org/10.6004/jnccn.2026.7061

Vancouver

Nusbaum DJ, Ferguson JE, Spiess PE, Li R, Fang AM, Sundi D, et al. New and Emerging Options for the Treatment of Non–Muscle-Invasive Bladder Cancer. Journal of the National Comprehensive Cancer Network. 2026;24(11). doi:10.6004/jnccn.2026.7061

BibTeX
@article{Nusbaum2026,
  author = {Nusbaum, David J and Ferguson, James E and Spiess, Philippe E and Li, Roger and Fang, Andrew M and Sundi, Debasish and Gilbert, Scott M and Peyton, Charles C},
  title = {New and Emerging Options for the Treatment of Non–Muscle-Invasive Bladder Cancer},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {11},
  doi = {10.6004/jnccn.2026.7061}
}
Kostenlos starten →